212 related articles for article (PubMed ID: 31597217)
1. Forkhead box C1 promotes metastasis and invasion of non-small cell lung cancer by binding directly to the lysyl oxidase promoter.
Gong R; Lin W; Gao A; Liu Y; Li J; Sun M; Chen X; Han S; Men C; Sun Y; Liu J
Cancer Sci; 2019 Dec; 110(12):3663-3676. PubMed ID: 31597217
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
[TBL] [Abstract][Full Text] [Related]
3. FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway.
Sun CC; Zhu W; Li SJ; Hu W; Zhang J; Zhuo Y; Zhang H; Wang J; Zhang Y; Huang SX; He QQ; Li DJ
Genome Med; 2020 Sep; 12(1):77. PubMed ID: 32878637
[TBL] [Abstract][Full Text] [Related]
4. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
5. Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration.
Wei L; Song XR; Sun JJ; Wang XW; Xie L; Lv LY
Cancer Biother Radiopharm; 2012 Dec; 27(10):672-7. PubMed ID: 23140307
[TBL] [Abstract][Full Text] [Related]
6. Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer Progression.
Lin YJ; Shyu WC; Chang CW; Wang CC; Wu CP; Lee HT; Chen LJ; Hsieh CH
Theranostics; 2017; 7(5):1177-1191. PubMed ID: 28435457
[TBL] [Abstract][Full Text] [Related]
7. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
8. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
Liu J; Ping W; Zu Y; Sun W
Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway.
Bai X; Shao J; Zhou S; Zhao Z; Li F; Xiang R; Zhao AZ; Pan J
J Exp Clin Cancer Res; 2019 Nov; 38(1):479. PubMed ID: 31783879
[TBL] [Abstract][Full Text] [Related]
10. Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signaling.
Nilsson G; Kannius-Janson M
BMC Cancer; 2016 Feb; 16():142. PubMed ID: 26908052
[TBL] [Abstract][Full Text] [Related]
11. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.
Ping W; Jiang WY; Chen WS; Sun W; Fu XN
Asian Pac J Cancer Prev; 2013; 14(6):3613-8. PubMed ID: 23886154
[TBL] [Abstract][Full Text] [Related]
12. Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression.
Liu J; Zhang Z; Li X; Chen J; Wang G; Tian Z; Qian M; Chen Z; Guo H; Tang G; Huang W; Tian D; Wang D; Nie Y; Fan D; Wu K; Xia L
Oncogene; 2018 Oct; 37(41):5477-5491. PubMed ID: 29884889
[TBL] [Abstract][Full Text] [Related]
13. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
[TBL] [Abstract][Full Text] [Related]
14. Forkhead box C1 boosts triple-negative breast cancer metastasis through activating the transcription of chemokine receptor-4.
Pan H; Peng Z; Lin J; Ren X; Zhang G; Cui Y
Cancer Sci; 2018 Dec; 109(12):3794-3804. PubMed ID: 30290049
[TBL] [Abstract][Full Text] [Related]
15. The effect of lysyl oxidase polymorphism on susceptibility and prognosis of nonsmall cell lung cancer.
Shi W; Yang B; Li X; Sun S; Wang L; Jiao S
Tumour Biol; 2012 Dec; 33(6):2379-83. PubMed ID: 22948781
[TBL] [Abstract][Full Text] [Related]
16. FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer.
Han B; Zhou B; Qu Y; Gao B; Xu Y; Chung S; Tanaka H; Yang W; Giuliano AE; Cui X
Oncogene; 2018 Mar; 37(10):1399-1408. PubMed ID: 29249801
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-204-5p inhibits invasion and metastasis of laryngeal squamous cell carcinoma by suppressing forkhead box C1.
Gao W; Wu Y; He X; Zhang C; Zhu M; Chen B; Liu Q; Qu X; Li W; Wen S; Wang B
J Cancer; 2017; 8(12):2356-2368. PubMed ID: 28819440
[No Abstract] [Full Text] [Related]
19. Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer.
Kalikawe R; Baba Y; Nomoto D; Okadome K; Miyake K; Eto K; Hiyoshi Y; Nagai Y; Iwatsuki M; Ishimoto T; Iwagami S; Miyamoto Y; Yoshida N; Watanabe M; Baba H
Cancer Sci; 2019 Dec; 110(12):3727-3737. PubMed ID: 31599475
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
